• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Is My Pulmonary Hypertension Doctor an Expert?

July 24, 2019 By Dr. Jeremy Feldman

A 25-year old woman develops slowly progressive shortness of breath.  After two years of wrong turns in her health care she eventually gets an echocardiogram that suggests pulmonary hypertension.  She has a right heart catheterization that confirms severe PAH.  She is referred to a local pulmonologist who starts her on one oral medication.  She improves a bit but continues to have shortness of breath with exertion and fatigue.  

Over the next 6 months her symptoms progress and her local pulmonologist keeps changing oral medications. Three years after she first developed symptoms of shortness of breath the patient is hospitalized at her local hospital with severe right heart failure.  She develops kidney and liver failure and dies. 

Was this young woman’s death avoidable?  Was her treating PAH doctor really an expert in treating PAH?  Why was she never placed on continuously infused prostanoid therapy?  Why was she never referred to a center of excellence?

PAH is a rare complicated disease.  Without proper treatment patients will progress and die from right heart failure. Effective treatments are now available. As more therapies have entered the market decision making around choosing the best therapy has become progressively more complicated.  

During this same time, more and more physicians are claiming to have expertise in treating PAH.  It seems that many local hospitals are now boasting of having a pulmonary hypertension program.  How can this be when each year a small handful of new PAH specialists are trained across the entire country?  

The short answer is they are not PAH “Programs”. Perhaps they have a physician or two interested in the disease, perhaps they are excited about all of the research currently taking place around PAH and want to participate, perhaps they see upside in all of the testing (echocardiograms, right heart catheterizations, etc.) required to care for PAH patients. But they are not PAH experts.  

How can you tell if your PAH doctor is truly an expert in treating this disease?  

First, ask what kind of training your doctor has received in PAH.  There are no general pulmonary or cardiology fellowship programs that train doctors adequately to be expert in treating PAH.  Being an expert requires additional training.  Ask your doctor how many of their PAH patients are being treated with continuously infused therapies like treprostinil (remodulin) or epoprostenol (veletri or flolan).  Imagine taking your car to a mechanic who only is comfortable using a few of the wrenches and tools.  A PAH physician who only uses oral therapy is not capable of delivering the best PAH care for PAH patients.  

How can you tell if your PAH program is really a Center of Excellence?  

PH TEAM

First and foremost, the PHA has developed a credentialing process recognizing the best PAH programs in America.  In order to earn the label Comprehensive Care Center these PAH programs must undergo a rigorous review process.  They must have super-specialized physicians who are expert in all PAH medications. Expert nurse coordinators must be part of the team to help patients navigate the complex journey of PAH.  The affiliated hospitals must have nurses and staff that are highly trained in the care of PAH patients.  The program must participate in clinical research helping to advance the care of PAH patients.  These dedicated physicians must publish papers advancing the science of caring for PAH patients.  These expert PAH physicians and nurses must be active in local, regional and national education and advocacy for PAH patients.  

I have heard from around the county that many local hospitals are setting up PAH programs.  The physicians that these hospitals have chosen to participate in these programs often have little PAH experience and the hospitals typically have little or no experience in the care of PAH patients.  Nursing staff in the hospitals often have little or no experience and the hospitals often don’t even carry all the needed medications.  These same hospitals typically don’t have lung transplant services.  These same programs are usually not recognized by the PHA as regional or comprehensive care centers.  The fact that the hospital is interested in PAH does not mean that they can deliver the best care.  What can you do as a PAH patient or advocate of a PAH patient?  Don’t be shy.  Do some research on your PAH doctor and the hospital you might visit.  If they don’t have the credentials then perhaps ask for a second opinion at a PHA recognized Comprehensive Care Center.  

Filed Under: PH Doctors & Centers

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Massachusetts Pulmonary Hypertension Task Force

Massachusetts – First State to Create PAH Task Force

By Dr. Jeremy Feldman

  The first PAH State Task Force has been created in Massachusetts. The purpose of the force is to monitor

pumpkin pie holiday food salt intake

The Holiday Season and Pulmonary Arterial Hypertension

By Dr. Jeremy Feldman

The holiday season is upon us and there will be many temptations over the next six weeks.  Is there a way to enjoy the

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives